Key Highlights
- ARK Invest offloaded 19,491 AMD shares valued at approximately $9.9 million from its ARKK ETF holdings
- The firm acquired 575,700 Archer Aviation shares for $3.4 million, doubling down on urban air mobility technology
- ARK purchased 93,290 Cerebras Systems shares worth $17.2 million even as the stock declined 32.4% from its May peak
- Cerebras delivered impressive Q2 results with 103% revenue growth reaching $209.9 million, plus 287% cloud revenue expansion
- Palantir Technologies shares worth $6.5 million were sold, while biotech positions in Beam Therapeutics and CRISPR Therapeutics expanded
ARK Invest, led by Cathie Wood, executed several significant portfolio adjustments on September 9, 2026, divesting from prominent technology holdings while increasing exposure to artificial intelligence infrastructure and biotechnology sectors.
The most substantial divestment involved Advanced Micro Devices, with ARK liquidating 19,491 shares via its ARKK ETF for approximately $9.9 million. This transaction extends ARK’s recent trend of scaling back its AMD exposure throughout the previous week.
Advanced Micro Devices, Inc., AMD
Additionally, ARK divested 38,395 Palantir Technologies shares valued at $6.5 million and decreased its Tempus AI holdings by selling 68,759 shares for $4.4 million.
Meanwhile, ARK’s acquisitions included 575,700 Archer Aviation shares for $3.4 million. The electric air taxi developer represents ARK’s expanding commitment to the emerging urban air mobility sector.
ARK Increases Cerebras Position Amid Price Weakness
The most noteworthy transaction involves ARK’s persistent accumulation of Cerebras Systems shares. On August 25, the firm acquired 93,290 shares distributed across two ETFs, representing approximately $17.2 million at execution prices.
Cerebras stock has experienced significant downward pressure recently. Shares declined 8% over the past month and have fallen 32.4% since the company’s May 14 market debut. The downturn intensified following the August 18 Supernova event when profit-taking accelerated.
Nevertheless, Wood appears confident in the company’s fundamental trajectory. Cerebras delivered Q2 revenue of $209.9 million, representing a substantial 103% increase compared to the previous year. Cloud services revenue specifically reached $127.7 million, surging 287% year-over-year.
Profitability metrics have raised some concerns. The core gross margin registered 40.6% during Q2, declining from Q1’s 46.5%. Company leadership attributes this pressure to temporary factors, specifically the expensive practice of leasing back systems from cloud partners.
Management anticipates margin recovery by Q4 as the company deploys additional owned infrastructure. Over the longer term, executives are projecting core gross margins exceeding 60%.
Financial Position and Market Outlook for Cerebras
Cerebras concluded Q2 with a robust balance sheet featuring over $8.6 billion in combined cash, restricted cash, and marketable securities. The company also maintains access to an untapped $850 million revolving credit line.
The organization has locked in more than 600 megawatts of data center capacity, with systems either operational or scheduled for activation by year-end 2027. Manufacturing capabilities have quadrupled compared to the first half of 2025.
Within ARK’s portfolio, Cerebras represents 2.68% of the ARK Innovation ETF allocation and 2.73% of the ARK Next Generation Internet ETF.
Analyst sentiment remains predominantly bullish, with 8 of 11 Wall Street analysts assigning Strong Buy ratings to Cerebras. The consensus price target of $283.91 suggests potential appreciation of 35.1%, while the most optimistic forecast of $330 indicates possible gains of 57.1% within the next twelve months.
During the identical trading session, ARK also accumulated shares of Beam Therapeutics, CRISPR Therapeutics, and Robinhood Markets, while simultaneously reducing holdings in Twist Bioscience and 10X Genomics.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
